Key facts
- It has raised $880K; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include Bayern Kapital, Capacura, DocMorris (Internet Retail), Martin Bluggel, Maruti Suzuki Innovation — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Caire
- ·The full record, as it builds
Funding rounds
No funding rounds for Caire are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Caire
Developer of contactless health measurement software designed for clinical and remote monitoring purposes. The company's software uses camera-based remote photoplethysmography and artificial intelligence to extract vital signs such as heart rate, breathing rate, heart rate variability, oxygen saturation, and stress indicators from standard cameras in real time without physical contact or additional hardware, enabling healthcare providers, telehealth platforms, and care organizations to monitor patients remotely, support clinical workflows, and access health data efficiently.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2021
- Employees
- 7
- Website
- caire.ai/
- Ownership
- Privately Held (backing)
Caire doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Caire shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Caire in its N-PORT filings yet. We sweep new filings monthly.